Ovid Therapeutics (OVID) EBITDA Margin Growth (1y) (2022 - 2025)
Ovid Therapeutics (OVID) EBITDA Margin Growth (1y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,981.90 Bn | 66,981.62 Bn | - | - |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 472.03 Bn | 467.24 Bn | 1.35 Bn | 1,552.00 |
| 5 | Vertex Pharmaceuticals | 122.09 Bn | 114.84 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 70.01 Bn | 61.26 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.99 Bn | 50.80 Bn | 1.41 Bn | 1,049.00 |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | 1,997.00 |
| 10 | Ovid Therapeutics | 120.41 Mn | -35.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.24 Mn |
| Sep 30, 2025 | -184,203.00 |
| Jun 30, 2025 | 1.21 Mn |
| Mar 31, 2025 | 211,440.00 |
| Dec 31, 2024 | -129,944.00 |
| Sep 30, 2024 | 339,069.00 |
| Jun 30, 2024 | 675,576.00 |
| Mar 31, 2024 | 1.08 Mn |
| Dec 31, 2023 | 1.35 Mn |
| Sep 30, 2023 | 10.43 Mn |
| Mar 31, 2023 | -2.14 Mn |
| Mar 31, 2022 | -121,019.00 |